Consumer Research
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system ...
Australia’s Medicinal Cannabis Imports Hit Record Highs
SYDNEY – Figures released this week by Australia's Office of ...
California Reinstates 15% Cannabis Excise Tax Through 2028
LOS ANGELES – A measure signed by Governor Gavin Newsom ...
AYR Wellness Secures Extension of Debt Waiver Ahead of Financial Deadline
LOS ANGELES- AYR Wellness Inc. a vertically integrated multi-state cannabis operator, announced on July 11, 2025, that it has secured an additional amendment to its Limited Waiver Agreement with holders of a majority of its senior ...
Americans Overwhelmingly Oppose Federal Cannabis Prohibition
LOS ANGELES- A recent survey by the Pew Research Center reveals that just 12 percent of U.S. adults support a federal prohibition on cannabis, with the remaining 88 percent favoring legalization in some form—either solely ...
Republican Lawmakers Move to Block Cannabis Rescheduling, Undermining Federal Reform Efforts
WASHINGTON, D.C.. Just as the Biden administration’s long-awaited cannabis rescheduling effort appeared to be gaining traction, Republicans in the House Appropriations Committee have moved to shut it down—using their control of a key budget bill ...
Texas Republicans Approve Total Ban on Hemp-Derived THC Products
DALLAS-In a sweeping move that could reshape Texas' booming hemp industry, the state House of Representatives has passed an amended version of Senate Bill 3 that bans all hemp products containing any form or amount ...
Analysis: Germany Legalized Cannabis. Now the Real Work Begins.
BERLIN-On April 1, 2024, Germany made history by legalizing adult-use cannabis. But legalization was only the first step. More than a year later, the rollout has exposed the complexities of implementing cannabis reform in a ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
Challenges Emerge Over Kentucky’s Medical Cannabis License Lottery
LOS ANGELES- A coalition of Kentucky-based businesses has filed legal proceedings challenging the fairness and constitutionality of the state’s April 2024 medical cannabis license lottery. The lawsuit, lodged in Jefferson Circuit Court on June 27, ...
Aegis Capital Maintains Buy Rating on atai Life Sciences with $8 Target
LOS ANGELES- Aegis Capital has reaffirmed its Buy rating on atai Life Sciences N.V. (NASDAQ: ATAI), maintaining a price target of $8 following the release of positive Phase 2b results for BPL-003, the company’s investigational ...
ICE Raids California Cannabis Farms as Budget Swells and Allegations Mount
CARPINTERIA, Calif. — In a sweeping operation that has stirred legal, political, and cultural tensions across California, federal immigration authorities executed high-profile raids on two cannabis farms operated by Glass House Brands, one of the ...
